MitoSciences is awarded "Mitochondrial Test Development" grant from NIH

Eugene, OR — MitoSciences has been awarded a $140,000 STTR (Small Business Technology Transfer) Phase I research grant from the National Institutes of Health to develop diagnostic and research tests for mitochondrial enzymes. Defects in these enzymes are responsible for inherited disorders of cellular energy metabolism and may be involved in degenerative diseases such as Parkinson's and Alzheimer's disease. The work is based on technologies and unique antibody proteins developed at the University of Oregon and licensed by MitoSciences and will be done in partnership between the two organizations. MitoSciences is a new biotechnology company located in the University of Oregon Riverfront Research Park. The company provides protein-based research reagents and kits to the global research community and is developing diagnostic tests for mitochondrial disorders.